Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIG1 hypoxia inducible domain family member 1A pseudogene (ENSG00000271455) is a non-coding sequence in the human genome that resembles the protein-coding gene HIGD1A but contains mutations and disruptions (such as frameshifts, premature stop codons, or deletions) that prevent it from encoding a functional protein[4][1][8]. Pseudogenes such as this may arise via duplication or retrotransposition of the parental gene, but typically do not produce proteins or act as therapeutic targets. Though some pseudogenes can regulate their parental genes through RNA-mediated mechanisms or be involved in epigenetic regulation, there is no evidence that ENSG00000271455 has such functionality. The functional parental gene, HIGD1A, is involved in mitochondrial homeostasis and the cellular response to hypoxia[3], but these activities do not apply to the pseudogene variant addressed here.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIG1 hypoxia inducible domain family, member 1A pseudogene (HIGD1AP).